US Stock MarketDetailed Quotes

IBRX ImmunityBio

Watchlist
  • 3.620
  • +0.300+9.04%
Close Feb 14 16:00 ET
  • 3.660
  • +0.040+1.10%
Post 20:01 ET
2.64BMarket Cap-3.98P/E (TTM)

About ImmunityBio Company

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

Company Profile

SymbolIBRX
Company NameImmunityBio
Listing DateJul 28, 2015
Issue Price25.00
Founded2014
CEOMr. Richard Adcock
MarketNASDAQ
Employees628
Fiscal Year Ends12-31
Address3530 John Hopkins Court
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-844-696-5235
Websitehttp://www.immunitybio.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard Adcock
  • Chief Executive Officer, President and Director
  • 1.16M
  • David C. Sachs
  • Chief Financial Officer
  • 1.06M
  • Dr. Barry J. Simon, M.D.
  • Chief Corporate Affairs Officer and Director
  • --
  • Dr. Patrick Soon-Shiong, F.A.C.S.,M.D.
  • Executive Chairman of the Board, Global Chief Scientific and Medical Officer
  • 865.34K
  • Regan J. Lauer
  • Chief Accounting Officer
  • --
  • Dr. Linda Maxwell, M.B.A.,M.D.
  • Independent Director
  • 487.50K
  • Michael D. Blaszyk
  • Independent Director
  • 510.00K
  • Cheryl L. Cohen
  • Lead Independent Director
  • 506.25K
  • General Sir Wesley Kanne Clark
  • Independent Director
  • 465.00K
  • Christobel Selecky
  • Independent Director
  • 470.00K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
PILOT
831175
+30.00%
XINGANJIANG
873167
+25.21%
Beijing Highlander Digital Technology
300065
+20.05%
4
Xiamen Hongxin Electronics Technology Group Inc.
300657
+20.01%
5
Shijihengtong Technology
301428
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!